Non Melanoma Skin Cancer clinical trials

Explore recruiting non melanoma skin cancer clinical trials.

Recruiting non melanoma skin cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Non Melanoma Skin Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions.

Poland, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial to investigate the efficacy and safety of daxdilimab subcutaneous injection in reducing disease activity in adult participants with moderate-to-severe primary discoid lupus erythematosus.

Denmark, France, Czechia, Germany, Poland, Greece +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Efficacyand Safety Study Of Daxdilimab Subcutaneous Injection In Adult Participants With Inadequately Controlled Dermatomyositis Or Anti-Synthetase Inflammatory Myositis

Spain, Italy, Germany, Czechia, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Non Melanoma Skin Cancer trials by city

Non Melanoma Skin Cancer in Toronto Non Melanoma Skin Cancer in Vancouver Non Melanoma Skin Cancer in Montreal Non Melanoma Skin Cancer in Calgary Non Melanoma Skin Cancer in Edmonton Non Melanoma Skin Cancer in Ottawa Non Melanoma Skin Cancer in Winnipeg Non Melanoma Skin Cancer in Quebec City Non Melanoma Skin Cancer in Hamilton Non Melanoma Skin Cancer in Kitchener Non Melanoma Skin Cancer in London Non Melanoma Skin Cancer in Halifax Non Melanoma Skin Cancer in New York Non Melanoma Skin Cancer in Los Angeles Non Melanoma Skin Cancer in Chicago Non Melanoma Skin Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease